Improving Infection Reporting in Hematology Treatment Trials
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Sennett C, Pula G Cells. 2025; 14(5).
PMID: 40072064 PMC: 11898727. DOI: 10.3390/cells14050335.
Improving reporting of infection events in clinical trials.
Ludwig H, Munshi N, Terpos E, Raje N, Moreau P, Nooka A Blood Adv. 2024; 8(22):5927-5928.
PMID: 39110989 PMC: 11662264. DOI: 10.1182/bloodadvances.2024014102.
References
1.
Teh B, Mikulska M, Averbuch D, de la Camara R, Hirsch H, Akova M
. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. Lancet Infect Dis. 2023; 24(1):e59-e68.
DOI: 10.1016/S1473-3099(23)00377-8.
View
2.
Tau N, Shargian-Alon L, Reich S, Paul M, Gafter-Gvili A, Shepshelovich D
. Reporting infections in clinical trials of patients with haematological malignancies. Clin Microbiol Infect. 2019; 25(12):1494-1500.
DOI: 10.1016/j.cmi.2019.04.029.
View
3.
Ludwig H, Munshi N, Terpos E, Schweitzer I, Raje N, Moreau P
. Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma. Blood Adv. 2024; 8(18):4979-4982.
PMC: 11496977.
DOI: 10.1182/bloodadvances.2024013461.
View
4.
Cordonnier C, Maschmeyer G, Cesaro S, Ljungman P
. Reporting infectious complications in haematology clinical trials should be improved. Clin Microbiol Infect. 2019; 25(12):1451-1453.
DOI: 10.1016/j.cmi.2019.07.024.
View
5.
Reynolds G, Maclean M, Cliff E, Teh B, Thursky K, Slavin M
. Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis. Blood Adv. 2024; 8(13):3555-3559.
PMC: 11261259.
DOI: 10.1182/bloodadvances.2024012916.
View